Unlocking Critical Insights: The Essential Role of Microscopy in Urinalysis

In a recent webinar, Dr. Angela Harrison of Beckman Coulter explored how microscopic analysis transforms urinalysis from a simple screening test into a comprehensive diagnostic tool.
Unlocking Critical Insights: The Essential Role of Microscopy in Urinalysis

In a recent webinar, Dr. Angela Harrison of Beckman Coulter explored how microscopic analysis transforms urinalysis from a simple screening test into a comprehensive diagnostic tool. For laboratory directors and clinical professionals seeking to optimize their urinalysis workflows, understanding the clinical significance of what we observe under the microscope has never been more important.

Why Microscopy Matters: Beyond the Dipstick

Urinalysis encompasses three complementary approaches: physical examination (assessing color, clarity, and specific gravity), chemical examination (detecting proteins, glucose, and other markers), and microscopic examination. While automated chemistry analyzers have streamlined the first two components, microscopic analysis remains the gold standard for identifying casts, cells, crystals, and microorganisms that reveal the underlying pathology.1

The time-sensitive nature of urine samples makes proper handling critical. Urine composition begins changing immediately after collection. Ideally, samples should be examined within the first hour, though refrigeration at 4°C can preserve integrity for up to 24 hours. Any specimen older than 24 hours cannot reliably be used for urinalysis—a reminder that workflow optimization directly impacts diagnostic accuracy.2

Download document

 

Reading Between the Crystals: What Microscopy Reveals

Casts: Early Warning Signs of Kidney Disease

Urinary casts form within the nephron during periods of urinary concentration or stasis, with all casts sharing a core matrix of uromodulin protein secreted by renal tubular cells.3 The presence and type of casts often signal serious underlying kidney conditions:

  • Red blood cell casts typically indicate glomerulonephritis, vasculitis, or intrinsic renal disease.4
  • White blood cell casts point toward pyelonephritis or interstitial nephritis5
  • Epithelial cell casts may suggest acute tubular injury, transplant rejection, or heavy metal poisoning6
  • Waxy (broad) casts are associated with advanced renal failure and dilated tubules with decreased flow7

Importantly, while hyaline casts can be normal findings (up to 5 per low-power field), their presence—especially in concentrated urine—can also indicate pyelonephritis or chronic renal disease when clinical context warrants concern.8

Three Patient Journeys: From Symptoms to Diagnosis

Dr. Harrison illustrated the clinical utility of microscopic urinalysis through several patient cases that demonstrate how comprehensive testing leads to accurate diagnosis and targeted treatment.

Case 1: Urinary Tract Infection

A 39-year-old woman presented with frequent urination, urinary discomfort, and elevated temperature. Her diagnostic journey included urine chemistry, microscopic review, and complete blood count testing.

Microscopic findings revealed bacteria, white blood cells, and red blood cells—hallmarks of a lower urinary tract infection. The sample was sent for culture and antibiotic susceptibility testing, ensuring she received the most effective antibiotic treatment rather than empiric therapy that might prove ineffective.

This case underscores a critical point: uncomplicated UTIs are among the most common bacterial infections encountered in clinical practice, yet accurate diagnosis requires the combination of symptoms, urinalysis results, and culture confirmation. Microscopy bridges the gap between presumptive chemical testing and definitive microbiological diagnosis.9

Case 2: Chronic Kidney Disease

A 52-year-old male with hypertension and diabetes presented with similar urinary symptoms. His extensive workup included urea, electrolyte, and creatinine testing alongside urinalysis.

The microscopic examination revealed urinary casts—often one of the first early indicators of underlying kidney disease. Combined with an estimated glomerular filtration rate (eGFR) of less than 60 ml/min/1.73 m², this led to a diagnosis of Chronic Kidney Disease (CKD).

Early detection through simple urine and blood tests enables better patient outcomes.10 Most cases of CKD produce no symptoms until advanced stages, making urinalysis an invaluable screening tool.11 The 2024 KDIGO guidelines emphasize that specific stages of CKD, characterized by GFR and albuminuria levels, independently predict greater risk for adverse outcomes12—making accurate microscopic analysis essential for risk stratification.13

Case 3: Urinary Cancer Screening

While not detailed in a specific case study, Dr. Harrison highlighted how microscopic urinalysis contributes to cancer detection. Proteinuria may indicate kidney problems, hypertension, or cancer in the urinary tract.14 Hematuria could signal bleeding caused by malignancy,15 while increased epithelial cells may suggest infection, inflammation, or cancer.16

Nearly all bladder cancers are urothelial carcinomas beginning in cells that line the urethra, bladder, ureters, and renal pelvis. Though urinalysis alone cannot diagnose cancer, abnormal findings prompt the additional imaging and cystoscopy needed for definitive diagnosis.17

Crystals: Normal Findings or Clinical Concern?

Crystal identification requires both technical skill and clinical context. Many crystals can appear in normal urine, while others indicate specific pathological conditions:

  • Calcium oxalate crystals (the most common type) appear as refractile "envelope" shapes and may indicate ethylene glycol poisoning, though they're also found in normal urine18
  • Uric acid crystals are associated with acidic urine and hyperuricosuria19
  • Triple phosphate (struvite) crystals with their distinctive "coffin lid" appearance suggest UTI from urease-producing bacterial species like Proteus or Klebsiella species20
  • Cystine crystals are always abnormal, indicating the genetic disorder cystinuria21

The presence of crystals must always be interpreted alongside pH, specific gravity, and clinical presentation. Laboratory professionals serve as clinical detectives, connecting microscopic observations with patient outcomes.

A Holistic Diagnostic Approach

Dr. Harrison emphasized a fundamental principle that resonates across all diagnostic testing: diagnosis is never done with a single test in isolation. Rather, it requires a holistic picture integrating physical examination, laboratory testing, and specialized follow-up.

Urinalysis can serve as both a simple generalized health check and a specific tool for diagnosing conditions like chronic kidney disease. The versatility of this testing modality—from routine wellness screening to complex disease management—makes it an indispensable component of laboratory medicine.

For medical directors and laboratory managers, this translates to ensuring your teams have:

  • Proper training in microscopic identification techniques
  • Standardized protocols for sample handling and processing within critical timeframes
  • Quality control measures that maintain diagnostic accuracy
  • Clinical context that connects microscopic findings to patient care decisions

Looking Forward: Technology Meets Expertise

While automated urinalysis systems continue advancing, the expertise of trained laboratory professionals remains irreplaceable. Technology enhances our capabilities—improving efficiency, standardization, and throughput—but the interpretation of complex microscopic findings still requires human judgment informed by clinical knowledge.

As laboratories seek to balance operational efficiency with diagnostic excellence, the integration of advanced automation with skilled microscopic review represents the optimal pathway forward. This partnership between technology and expertise ensures that no clinically significant finding goes undetected, while streamlining workflows for routine cases.

References:

1. Allison B Chambliss, Holli M Mason, Tam T Van. Correlation of Chemical Urinalysis to Microscopic Urinalysis and Urine Culture: Implications for Reflex Urinalysis Workflows. J Appl Lab Med. 2020;5(4):724–731. doi:10.1093/jalm/jfaa011

2. Paul Froom, Barbara Bieganiec, Zahava Ehrenrich, Mira Barak. Stability of Common Analytes in Urine Refrigerated for 24 h before Automated Analysis by Test Strips. Clin Chem. 2000;46(9):1384–1386. doi:10.1093/clinchem/46.9.1384

3. Karagiannidis A, Theodorakopoulou M, Pella E, Sarafidis PA, Ortiz A. Uromodulin biology. Nephrol Dial Transplant. 2024;39(7):1073-1087. doi:10.1093/ndt/gfae008.

4. Kitamura M, Biederman L, Ibrahim D, et al. Correlation of red blood cell casts with renal dysfunction in patients with infection-related glomerulonephritis. Arch Pathol Lab Med. 2024;148(5):545-552. doi:10.5858/arpa.2022-0514-OA

5. White Cell Casts. In: Wexler P, ed. Encyclopedia of Toxicology. 4th ed. Springer; 2024:152-154. doi:10.1007/978-981-99-9187-7_152

6. Houston SJ, Sanders ML, Harshman LA. The physiology of urinary cast formation. In: Sharp VJ, ed. Urine Tests: Practical and Useful Tips for Busy Clinicians. Springer; 2020:189-204. doi:10.1007/978-3-030-29138-9_10.

7. Xu D, Li J, Wang S, et al. The clinical and pathological relevance of waxy casts in urine sediment. Ren Fail. 2022;44(1):1038-1044. doi:10.1080/0886022X.2022.2088388.

8. Levels Team. Guide to casts in urine. Levels. Updated May 22, 2025. Accessed November 14, 2025.

9. Karagiannidis A, et al. Uromodulin biology. Nephrol Dial Transplant. 2024;39(7):1073-1087. doi:10.1093/ndt/gfae008

10. Bermudez T, Schmitz JE, Boswell M, Humphries R. Novel technologies for the diagnosis of urinary tract infections. J Clin Microbiol. 2025;63(2):e00306-24. doi:10.1128/JCM.00306-24.

11. Kushner P, Khunti K, Cebrián A, Deed G. Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners. Adv Ther. 2024;41:3757–3770. doi:10.1007/s12325-024-02957-z

12. Obrador GT, Tonelli M. Early detection of chronic kidney disease. UpToDate. Updated Feb 09, 2024. Accessed November 14, 2025.

13. Kidney Disease: Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2024;105(4S):S117–S314. doi:10.1016/j.kint.2023.10.018

14. Lambrecht S, Speeckaert M, Oyaert M. Optimization of screening strategy for chronic kidney disease by urine test strips using the albumin-creatinine read-out. BMC Nephrol. 2025;26:130. doi:10.1186/s12882-025-04048-9

15. Torpy JM, Lynm C, Glass RM. Proteinuria | Urology. JAMA. 2010;303(5)

16. Ingelfinger JR. Hematuria in Adults. N Engl J Med. 2021;385(2):153163. doi:10.1056/NEJMra1604481

17. Epithelial and Squamous Cells in Urine. WebMD. Published May 6, 2025.

18. Sanli O, Dobruch J, Knowles MA, et al. Bladder cancer. Nat Rev Dis Primers. 2017;3:17022. doi:10.1038/nrdp.2017.22

19. Kraut JA, Mullins ME. Toxic Alcohols. N Engl J Med. 2018;378(3):270-280. doi:10.1056/NEJMra1615295.

20. Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther. 2010;12(6):223. doi:10.1186/ar3199.

21. Flannigan R, Choy WH, Chew B, Lange D. Renal struvite stones—pathogenesis, microbiology, and management strategies. Nat Rev Urol. 2014;11(6):333-341. doi:10.1038/nrurol.2014.99.

22. Dello Strologo L, Pras E, Pontesilli C, et al. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol. 2002;13(10):2547-2553. doi:10.1097/01.ASN.0000030073.72296.6F.

For laboratory professionals seeking to deepen their understanding of urinalysis or explore how Beckman Coulter solutions can enhance your laboratory's capabilities, the full webinar recording provides detailed microscopic images, comprehensive reference ranges, and practical insights from Dr. Harrison's clinical experience. https://app.livestorm.co/beckman-coulter-dx-hgm/on-demand-webinar-unlocking-insights-the-power-of-microscopy-in-urinalysis?s=147714ff-e0ef-4ab2-ae9f-fd909462464c

2025-15000

Kanochia Johnson
Kanochia Johnson
Kanochia Johnson, MBA, is a Global Product Marketing Manager with more than 20 years of experience integrating clinical expertise and business strategy to advance healthcare innovation.

Featured Articles

Advancing Clinical Capabilities to Empower Better Outcomes

Advancing Clinical Capabilities to Empower Better Outcomes

Discover how our philosophy of Advancing Clinical Capabilities is helping us deliver greater insights in areas like women’s health, cardiovascular disease, infectious disease, and beyond.
Rethinking Heart Failure Diagnosis in an Era of Rising Obesity

Rethinking Heart Failure Diagnosis in an Era of Rising Obesity

As obesity rates climb toward 50% of the U.S. population, clinicians face a growing diagnostic challenge: obesity is associated with lower NT-proBNP levels, potentially masking heart failure in the patients most at risk.
The Global Burden of Cardiovascular Disease in Women

The Global Burden of Cardiovascular Disease in Women

Based on "Women's Hearts: Biomarkers for Precision-based Care," a webinar with Dr. Emily Lau, MD, MPH. Dr. Lau is a cardiologist and public health expert specializing in cardiovascular disease prevention, heart failure, and women’s cardiac health. Her research focuses on risk prediction, sex-based differences in cardiovascular disease, and strategies to improve outcomes through evidence-based care.